{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:46:00Z","timestamp":1782582360922,"version":"3.54.5"},"reference-count":51,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Pavia: Fondi Ricerca Giovani","award":["FRG 2021"],"award-info":[{"award-number":["FRG 2021"]}]},{"name":"Italian Ministry of Education, University and Research (MIUR)","award":["FRG 2021"],"award-info":[{"award-number":["FRG 2021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Malignant mesothelioma is a rare tumor associated with asbestos exposure. Mesothelioma carcinogenesis is related to enhanced reactive oxygen species (ROS) production and iron overload. Despite the recent advances in biomedical sciences, to date the only available treatments include surgery in a small fraction of patients and platinum-based chemotherapy in combination with pemetrexed. In this view, the purpose of this study was to evaluate the therapeutic potential of the newly synthetized platinum prodrug Pt(IV)Ac-POA compared to cisplatin (CDDP) on human biphasic mesothelioma cell line MSTO-211H using different complementary techniques, such as flow-cytometry, transmission electron microscopy (TEM), and immunocytochemistry. Healthy mesothelial cell lines Met-5A were also employed to assess the cytotoxicity of the above-mentioned compounds. Our in vitro results showed that Pt(IV)Ac-POA significantly interfere with iron metabolisms and more importantly is able to trigger cell death, through different pathways, including ferroptosis, necroptosis, and apoptosis, in neoplastic cells. On the other hand, CDDP triggers mainly apoptotic and necrotic cell death. In conclusion, Pt(IV)Ac-POA may represent a new promising pharmacological agent in the treatment of malignant mesothelioma.<\/jats:p>","DOI":"10.3390\/pharmaceutics16081015","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T08:02:27Z","timestamp":1722412947000},"page":"1015","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4893-0405","authenticated-orcid":false,"given":"Cristina","family":"Favaron","sequence":"first","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-2277","authenticated-orcid":false,"given":"Ludovica","family":"Gaiaschi","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8002-8262","authenticated-orcid":false,"given":"Claudio","family":"Casali","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6462-2373","authenticated-orcid":false,"given":"Fabrizio","family":"De Luca","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Gola","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7071-1996","authenticated-orcid":false,"given":"Margherita","family":"Cavallo","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7727-2055","authenticated-orcid":false,"given":"Valeria","family":"Ramundo","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Via Santena 5\/bis, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0236-6175","authenticated-orcid":false,"given":"Elisabetta","family":"Aldieri","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Via Santena 5\/bis, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0454-1416","authenticated-orcid":false,"given":"Gloria","family":"Milanesi","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Damiana","family":"Vison\u00e0","sequence":"additional","affiliation":[{"name":"Unit of Legal Medicine and Forensic Sciences, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4732-7508","authenticated-orcid":false,"given":"Mauro","family":"Ravera","sequence":"additional","affiliation":[{"name":"Department of Sciences and Technological Innovation (DiSIT), University of Piemonte Orientale \u201cA. Avogadro\u201d,Via Teresa Michel 11, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-8785","authenticated-orcid":false,"given":"Maria Grazia","family":"Bottone","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3322\/caac.21572","article-title":"Mesothelioma: Scientific Clues for Prevention, Diagnosis, and Therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.21037\/atm.2017.04.29","article-title":"Mesothelioma: Recent Highlights","volume":"5","author":"Carbone","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-020-02980-9","article-title":"Challenges in Lung and Thoracic Pathology: Molecular Advances in the Classification of Pleural Mesotheliomas","volume":"478","author":"Mangiante","year":"2021","journal-title":"Virchows Arch."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"200226","DOI":"10.1183\/16000617.0226-2020","article-title":"Update on Biology and Management of Mesothelioma","volume":"30","author":"Asciak","year":"2021","journal-title":"Eur. Respir. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.freeradbiomed.2018.10.401","article-title":"Iron Addiction with Ferroptosis-Resistance in Asbestos-Induced Mesothelial Carcinogenesis: Toward the Era of Mesothelioma Prevention","volume":"133","author":"Toyokuni","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0891-5849(95)02111-6","article-title":"Iron-Induced Carcinogenesis: The Role of Redox Regulation","volume":"20","author":"Toyokuni","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.21037\/tlcr.2017.05.06","article-title":"Diagnostic and Prognostic Biomarkers for Malignant Mesothelioma: An Update","volume":"6","author":"Chen","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant Mesothelioma: Facts, Myths, and Hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1289\/ehp.1002845","article-title":"Global Magnitude of Reported and Unreported Mesothelioma","volume":"119","author":"Park","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/15287394.2015.1123452","article-title":"Iron Signature in Asbestos-Induced Malignant Pleural Mesothelioma: A Population-Based Autopsy Study","volume":"79","author":"Crovella","year":"2016","journal-title":"J. Toxicol. Environ. Health\u2014Part A Curr. Issues"},{"key":"ref_11","first-page":"143","article-title":"A Comparison of the Ferruginous Body and Uncoated Fiber Content in the Lungs of Former Asbestos Workers","volume":"132","author":"Dodson","year":"1985","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Vison\u00e0, S.D., Capella, S., Bodini, S., Borrelli, P., Villani, S., Crespi, E., Colosio, C., Previder\u00e8, C., and Belluso, E. (2021). Evaluation of Deposition and Clearance of Asbestos (Detected by SEM-EDS) in Lungs of Deceased Subjects Environmentally and\/or Occupationally Exposed in Broni (Pavia, Northern Italy). Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.678040"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.freeradbiomed.2017.04.368","article-title":"Non-Thermal Plasma Induces a Stress Response in Mesothelioma Cells Resulting in Increased Endocytosis, Lysosome Biogenesis and Autophagy","volume":"108","author":"Shi","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.lfs.2018.08.048","article-title":"A New Platinum-Based Prodrug Candidate: Its Anticancer Effects in B50 Neuroblastoma Rat Cells","volume":"210","author":"Rangone","year":"2018","journal-title":"Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14174","DOI":"10.1039\/C7DT02928D","article-title":"An Unsymmetric Cisplatin-Based Pt(IV) DerIVatIVe Containing 2-(2-Propynyl)Octanoate: A Very Efficient Multi-Action Antitumor Prodrug Candidate","volume":"46","author":"Gabano","year":"2017","journal-title":"Dalton Trans."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"215578","DOI":"10.1016\/j.ccr.2023.215578","article-title":"Platinum(IV) and Platinum(II) Anticancer Complexes with Biologically Active Releasable Ligands","volume":"501","year":"2024","journal-title":"Coord. Chem. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"213640","DOI":"10.1016\/j.ccr.2020.213640","article-title":"Platinum(IV) Antitumor Complexes and Their Nano-Drug Delivery","volume":"429","author":"Jia","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ica.2019.04.025","article-title":"A View on Multi-Action Pt(IV) Antitumor Prodrugs","volume":"492","author":"Ravera","year":"2019","journal-title":"Inorganica Chim. Acta"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.chemrev.8b00271","article-title":"Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?","volume":"119","author":"Kenny","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinorgbio.2013.09.003","article-title":"Antiproliferative Activity of Pt(IV)-Bis(Carboxylato) Conjugates on Malignant Pleural Mesothelioma Cells","volume":"129","author":"Alessio","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Almotairy, A.R.Z., Montagner, D., Morrison, L., Devereux, M., Howe, O., and Erxleben, A. (2020). Pt(IV) pro-Drugs with an Axial HDAC Inhibitor Demonstrate Multimodal Mechanisms Involving DNA Damage and Apoptosis Independent of Cisplatin Resistance in A2780\/A2780cis Cells. J. Inorg. Biochem., 210.","DOI":"10.1016\/j.jinorgbio.2020.111125"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/138945010790711923","article-title":"Valproic Acid in the Complex Therapy of Malignant Tumors","volume":"11","author":"Hrebackova","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer Activities of Histone Deacetylase Inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC Inhibitors in Cancer Development and Therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3892\/ijo.2016.3402","article-title":"The Levels of HDAC1 and Thioredoxin1 Are Related to the Death of Mesothelioma Cells by Suberoylanilide Hydroxamic Acid","volume":"48","author":"You","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/1541-7786.MCR-20-0434","article-title":"Dual Screen for Efficacy and Toxicity Identifies HDAC Inhibitor with Distinctive Activity Spectrum for BAP1-Mutant Uveal Melanoma","volume":"19","author":"Kuznetsoff","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13148-018-0517-9","article-title":"Assessment of New HDAC Inhibitors for Immunotherapy of Malignant Pleural Mesothelioma","volume":"10","author":"Bensaid","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/JTO.0b013e3181c5e366","article-title":"Histone Deacetylase Inhibitors in Malignant Pleural Mesothelioma: Preclinical Rationale and Clinical Trials","volume":"5","author":"Paik","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gaiaschi, L., Roda, E., Favaron, C., Gola, F., Gabano, E., Ravera, M., Rossi, P., and Bottone, M.G. (2022). The Power of a Novel Combined Anticancer Therapy: Challenge and Opportunity of Micotherapy in the Treatment of Glioblastoma Multiforme. Biomed. Pharmacother., 155.","DOI":"10.1016\/j.biopha.2022.113729"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s10495-023-01857-x","article-title":"Study on the Activation of Cell Death Mechanisms: In Search of New Therapeutic Targets in Glioblastoma Multiforme","volume":"28","author":"Gaiaschi","year":"2023","journal-title":"Apoptosis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2902985","DOI":"10.1155\/2019\/2902985","article-title":"Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy","volume":"2019","author":"Borchert","year":"2019","journal-title":"J. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","article-title":"Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma","volume":"15","author":"Vandermeers","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ferrari, B., Roda, E., Priori, E.C., De Luca, F., Facoetti, A., Ravera, M., Brandalise, F., Locatelli, C.A., Rossi, P., and Bottone, M.G. (2021). A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.589906"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Stirling, D.R., Swain-Bowden, M.J., Lucas, A.M., Carpenter, A.E., Cimini, B.A., and Goodman, A. (2021). CellProfiler 4: Improvements in Speed, Utility and Usability. BMC Bioinform., 22.","DOI":"10.1186\/s12859-021-04344-9"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jclinpath-2016-203866","article-title":"Gene of the Month: BAP1","volume":"69","author":"Wang","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 Mutations Predispose to Malignant Mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 Links Metabolic Regulation of Ferroptosis to Tumour Suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature22798","article-title":"BAP1 Regulates IP3R3-Mediated Ca2+ Flux to Mitochondria Suppressing Cell Transformation","volume":"546","author":"Bononi","year":"2017","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yang, H., Hall, S.R.R., Sun, B., Zhao, L., Gao, Y., Schmid, R.A., Tan, S.T., Peng, R.-W., Yao, F., and Stella, G.M. (2021). NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma. Cancers, 13.","DOI":"10.3390\/cancers13071561"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Deiana, C., Fabbri, F., Tavolari, S., Palloni, A., and Brandi, G. (2023). Improvements in Systemic Therapies for Advanced Malignant Mesothelioma. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310415"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2217\/fon-2015-0055","article-title":"Impact of Smoking on Lung Cancer Treatment Effectiveness: A Review","volume":"12","author":"Condoluci","year":"2016","journal-title":"Future Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101312","DOI":"10.1016\/j.tranon.2021.101312","article-title":"HDAC Inhibitors: Targets for Tumor Therapy, Immune Modulation and Lung Diseases","volume":"16","author":"Shanmugam","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Felley-Bosco, E., and Gray, S.G. (2019). Mesothelioma Driver Genes, Ferroptosis, and Therapy. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01318"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a New Form of Cell Death: Opportunities and Challenges in Cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Chen, J., Kos, R., Garssen, J., and Redegeld, F. (2019). Cells Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target. Cells, 8.","DOI":"10.3390\/cells8121486"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Favaron, C., Gabano, E., Zanellato, I., Gaiaschi, L., Casali, C., Bottone, M.G., and Ravera, M. (2023). Effects of Ferrocene and Ferrocenium on MCF-7 Breast Cancer Cells and Interconnection with Regulated Cell Death Pathways. Molecules, 28.","DOI":"10.3390\/molecules28186469"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (4th Edition)1","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","article-title":"Cell Death: A Review of the Major Forms of Apoptosis, Necrosis and Autophagy","volume":"43","year":"2019","journal-title":"Cell Biol. Int."},{"key":"ref_49","first-page":"1213","article-title":"Targeting Autophagy Is a Promising Therapeutic Strategy to Overcome Chemoresistance and Reduce Metastasis in Osteosarcoma (Review)","volume":"55","author":"Liao","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"25543","DOI":"10.1073\/pnas.2007622117","article-title":"Asbestos Induces Mesothelial Cell Transformation via HMGB1-Driven Autophagy","volume":"117","author":"Xue","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e2111946118","DOI":"10.1073\/pnas.2111946118","article-title":"BAP1 Forms a Trimer with HMGB1 and HDAC1 That Modulates Gene \u00d7 Environment Interaction with Asbestos","volume":"118","author":"Novelli","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/8\/1015\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:26:59Z","timestamp":1760110019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/8\/1015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["pharmaceutics16081015"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16081015","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}